Technical Analysis for CRNX - Crinetics Pharmaceuticals, Inc.

Grade Last Price % Change Price Change
grade F 24.58 0.41% 0.10
CRNX closed up 0.41 percent on Friday, February 15, 2019, on 83 percent of normal volume.

Earnings due: Feb 19

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent N/A Down Down
See historical CRNX trend table...

Date Alert Name Type % Chg
Feb 15 20 DMA Resistance Bearish 0.00%
Feb 15 Bullish Engulfing Bullish 0.00%
Feb 15 Bollinger Band Squeeze Range Contraction 0.00%
Feb 15 Doji - Bullish? Reversal 0.00%
Feb 15 BB Squeeze + Lower Band Touch Range Contraction 0.00%
Feb 15 Outside Day Range Expansion 0.00%
Feb 15 Lower Bollinger Band Touch Weakness 0.00%
Feb 14 Fell Below 20 DMA Bearish 0.41%
Feb 14 Bollinger Band Squeeze Range Contraction 0.41%
Feb 13 Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.12%

Older signals for CRNX ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Crinetics Pharmaceuticals, Inc. is a clinical stage pharmaceutical company. The Company is focused on the discovery and development of drugs to treat specialty endocrine diseases and endocrine-related tumors. It develops a pipeline of oral nonpeptide chemical entities that target peptide G protein coupled receptors (GPCRs) for the treatment of endocrine diseases. The Company’s lead product candidate is CRN00808 developed for the treatment of acromegaly. It also develops two other product candidates CRN02481 for hyperinsulinemia, and CRN01941 for the treatment of neuroendocrine tumors. CRN02481 and CRN01941 are both oral nonpeptide somastatin receptors that are in the pre-clinical stages of development. The company also conducts research programs on developing nonpeptide products for the treatment of Cushing’s disease.
Cancer Organ Systems Disease Endocrine System Pancreatic Cancer Acromegaly Neuroendocrinology Endocrine Diseases Neuroendocrine Tumors
Is CRNX a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 2 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 42.0
52 Week Low 19.23
Average Volume 59,006
200-Day Moving Average 0.0
50-Day Moving Average 27.2984
20-Day Moving Average 24.631
10-Day Moving Average 24.997
Average True Range 2.134
ADX 24.08
+DI 11.5781
-DI 27.4257
Chandelier Exit (Long, 3 ATRs ) 21.428
Chandelier Exit (Short, 3 ATRs ) 27.452
Upper Bollinger Band 27.0643
Lower Bollinger Band 22.1977
Percent B (%b) 0.49
BandWidth 19.758029
MACD Line -0.5217
MACD Signal Line -0.6321
MACD Histogram 0.1104
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 30.30
Resistance 3 (R3) 29.97 27.73 29.35
Resistance 2 (R2) 27.73 26.28 27.90 29.03
Resistance 1 (R1) 26.16 25.38 26.95 26.49 28.71
Pivot Point 23.92 23.92 24.31 24.08 23.92
Support 1 (S1) 22.34 22.46 23.13 22.67 20.45
Support 2 (S2) 20.10 21.56 20.27 20.13
Support 3 (S3) 18.53 20.10 19.81
Support 4 (S4) 18.86